Huang Dennis Karl 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Huang Dennis Karl
See Remarks
Transactions
- Award
Common Stock
[F1]2026-03-01+11,137→ 125,728 total - Tax Payment
Common Stock
[F2][F3]2026-03-02$23.39/sh−999$23,367→ 124,729 total
Footnotes (3)
- [F1]Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metric.
- [F2]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Signature
/s/ Karah Parschauer, attorney-in-fact|2026-03-03